ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed
Jingkai Liu
Matched on ORCID iD 0000-0003-0523-8213; OpenAlex author ID A5050876545. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2020: 2 papers · 2021: 3 papers
Papers 5
- Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. Co-author DOI 10.1007/s00262-020-02816-0↗
- Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy. Co-author DOI 10.1186/s12935-021-01824-z↗
- Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12935-021-02037-0↗
- Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment. Co-author DOI 10.1007/s00262-020-02542-7↗
- CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration. Co-author DOI 10.7150/jca.40517↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yalu Zhang · 3 shared papers, 2021 · strength 0.46
- Paper Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic … DOI 10.1186/s12935-021-02037-0↗
- Paper Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy. DOI 10.1186/s12935-021-01824-z↗
- Paper Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. DOI 10.1007/s00262-020-02816-0↗
- Xiang Zhang · 4 shared papers, 2020–2021 · strength 0.46
- Paper Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy. DOI 10.1186/s12935-021-01824-z↗
- Paper Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. DOI 10.1007/s00262-020-02816-0↗
- Paper CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell i… DOI 10.7150/jca.40517↗
- Ming Cui · 4 shared papers, 2020–2021 · strength 0.46
- Paper Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy. DOI 10.1186/s12935-021-01824-z↗
- Paper Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. DOI 10.1007/s00262-020-02816-0↗
- Paper CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell i… DOI 10.7150/jca.40517↗
- Tong Li · 4 shared papers, 2020–2021 · strength 0.46
- Paper Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy. DOI 10.1186/s12935-021-01824-z↗
- Paper Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. DOI 10.1007/s00262-020-02816-0↗
- Paper CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell i… DOI 10.7150/jca.40517↗
- Qiaofei Liu · 3 shared papers, 2020–2021 · strength 0.44
- Paper Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic … DOI 10.1186/s12935-021-02037-0↗
- Paper Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy. DOI 10.1186/s12935-021-01824-z↗
- Paper CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell i… DOI 10.7150/jca.40517↗
- Quan Liao · 2 shared papers, 2021 · strength 0.34
- Paper Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic … DOI 10.1186/s12935-021-02037-0↗
- Paper Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy. DOI 10.1186/s12935-021-01824-z↗
- Quan Liao · 3 shared papers, 2020–2021 · strength 0.31
- Paper Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. DOI 10.1007/s00262-020-02816-0↗
- Paper CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell i… DOI 10.7150/jca.40517↗
- Paper Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor micr… DOI 10.1007/s00262-020-02542-7↗
- Ronghua Zhang · 3 shared papers, 2020–2021 · strength 0.31
- Paper Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. DOI 10.1007/s00262-020-02816-0↗
- Paper CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell i… DOI 10.7150/jca.40517↗
- Paper Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor micr… DOI 10.1007/s00262-020-02542-7↗
- Qiaofei Liu · 2 shared papers, 2020–2021 · strength 0.20
- Paper Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. DOI 10.1007/s00262-020-02816-0↗
- Paper Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor micr… DOI 10.1007/s00262-020-02542-7↗
- Huanwen Wu · 2 shared papers, 2020–2021 · strength 0.20
- Paper Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. DOI 10.1007/s00262-020-02816-0↗
- Paper Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor micr… DOI 10.1007/s00262-020-02542-7↗
- Junyi Gao · 2 shared papers, 2020–2021 · strength 0.20
- Paper Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. DOI 10.1007/s00262-020-02816-0↗
- Paper Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor micr… DOI 10.1007/s00262-020-02542-7↗
- Yupei Zhao · 2 shared papers, 2020 · strength 0.19
- Paper CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell i… DOI 10.7150/jca.40517↗
- Paper Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor micr… DOI 10.1007/s00262-020-02542-7↗
- Sen Yang · 1 shared paper, 2021 · strength 0.12
- Mengyi Wang · 1 shared paper, 2020 · strength 0.11
- Junya Peng · 1 shared paper, 2020 · strength 0.11
- Li Zhou · 1 shared paper, 2020 · strength 0.09
- Boju Pan · 1 shared paper, 2020 · strength 0.09
- Weibin Wang · 1 shared paper, 2020 · strength 0.09
- Menghua Dai · 1 shared paper, 2020 · strength 0.09
- Taiping Zhang · 1 shared paper, 2020 · strength 0.09
- Wenming Wu · 1 shared paper, 2020 · strength 0.09
- Jorg H. Kleeff · 1 shared paper, 2020 · strength 0.09
- Junchao Guo · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.